CDKN2A/P16-INK4A Polyklonaler Antikörper

CDKN2A/P16-INK4A Polyklonal Antikörper für WB, FC (Intra), IP, ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human

Anwendung

WB, IHC, FC (Intra), IP, ELISA

Konjugation

Unkonjugiert

Publikationen(4)

Kat-Nr. : 30519-1-AP

Synonyme

p16, p16 INK4, P16 INK4A, p16-INK4, p16INK4A



Geprüfte Anwendungen

Erfolgreiche Detektion in WBHEK-293-Zellen, HeLa-Zellen
Erfolgreiche IPHEK-293-Zellen
Erfolgreiche Detektion in FC (Intra)HeLa-Zellen

Empfohlene Verdünnung

AnwendungVerdünnung
Western Blot (WB)WB : 1:1000-1:6000
Immunpräzipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Durchflusszytometrie (FC) (INTRA)FC (INTRA) : 0.80 ug per 10^6 cells in a 100 µl suspension
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Veröffentlichte Anwendungen

WBSee 3 publications below
IHCSee 1 publications below

Produktinformation

30519-1-AP bindet in WB, IHC, FC (Intra), IP, ELISA CDKN2A/P16-INK4A und zeigt Reaktivität mit human

Getestete Reaktivität human
In Publikationen genannte Reaktivitäthuman
Wirt / Isotyp Kaninchen / IgG
Klonalität Polyklonal
Typ Antikörper
Immunogen CDKN2A/P16-INK4A fusion protein Ag29567
Vollständiger Name cyclin-dependent kinase inhibitor 2A
Berechnetes Molekulargewicht 17 kDa
Beobachtetes Molekulargewicht 16 kDa
GenBank-ZugangsnummerNM_000077
Gene symbol CDKN2A
Gene ID (NCBI) 1029
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Antigen-Affinitätsreinigung
Lagerungspuffer PBS with 0.02% sodium azide and 50% glycerol
LagerungsbedingungenBei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

P16-INK4A is also named as CDKN2A, MLM, Tumor suppressor ARF, Alternative reading frame. The tumor suppressor protein p16Ink4a (encoded from the CDKN2A locus) is often transcriptionally activated in cells undergoing senescence and is one of the main regulators of this program, and it is upregulated in multiple tissues during aging (PMID:17055429). p16-Ink4a is the principal member of the Ink4 family of CDK inhibitors. p16-Ink4a contributes to the regulation of cell cycle progression by inhibiting the S phase. p16Ink4a binds to CDK4/6, inhibiting cyclin D-CDK4/6 complex formation and CDK4/6-mediated phosphorylation of Rb family members. Expression of p16-Ink4a maintains the Rb family members in a hypophosphorylated state, which promotes binding to E2F1 and leads to G1 cell cycle arrest (PMID: 21297668).

Protokolle

PRODUKTSPEZIFISCHE PROTOKOLLE
WB protocol for CDKN2A/P16-INK4A antibody 30519-1-APProtokoll herunterladen
IP protocol for CDKN2A/P16-INK4A antibody 30519-1-APProtokoll herunterladen
STANDARD-PROTOKOLLE
Klicken Sie hier, um unsere Standardprotokolle anzuzeigen

Publikationen

SpeciesApplicationTitle
humanWB

Biochim Biophys Acta Mol Cell Res

Suppression of GATA3 promotes epithelial-mesenchymal transition and simultaneous cellular senescence in human extravillous trophoblasts

Authors - En-Xiang Chen
IHC

Aging Cell

Identifying ENO1 as a protein target of chlorogenic acid to inhibit cellular senescence and prevent skin photoaging in mice

Authors - Xueling He
humanWB

Tissue Cell

Molecular changes of cellular senescence in dental pulp stem cells during in vitro culture: A potential role of PSG4

Authors - Xiaolin Lyu
WB

Front Aging

Tissue-specific effects of bacterial PncA overexpression on NAD+ metabolism and aging in mice: implications for tissue-specific aging interventions

Authors - Fengjiao Huo